Glen Eagle Advisors, LLC Invitae Corp Transaction History

Glen Eagle Advisors, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.0 - $0.01 $0 - $3	-300 Closed	0 $0
Q4 2021 Aug 13, 2024	SELL	$14.7 - $28.67 $7,276 - $14,191	-495 Closed	0 $0
Q1 2021 Aug 13, 2024	SELL	$33.06 - $56.93 $991 - $1,707	-30 Reduced 5.71%	495 $18.9 Million
Q4 2020 Aug 13, 2024	BUY	$39.09 - $57.4 $20,522 - $30,135	525 New	525 $22 Million
Q1 2020 Aug 13, 2024	BUY	$7.64 - $27.5 $191 - $687	25 Added 5.0%	525 $7.18 Million
Q4 2019 Aug 13, 2024	BUY	$15.02 - $20.57 $7,510 - $10,285	500 New	500 $8.07 Million
Q4 2018 Aug 13, 2024	SELL	$9.26 - $16.38 $1,389 - $2,457	-150 Closed	0 $0
Q3 2018 Aug 13, 2024	SELL	$7.54 - $18.31 $1,131 - $2,746	-150 Reduced 50.0%	150 $2.51 Million
Q1 2018 Aug 14, 2024	BUY	$4.69 - $10.05 $1,407 - $3,015	300 New	300 $1.41 Million
Q1 2018 Aug 13, 2024	BUY	$4.69 - $10.05 $1,407 - $3,015	300 New	300 $1.41 Million
Q4 2017 Aug 13, 2024	SELL	$7.86 - $9.99 $1,179 - $1,498	-150 Closed	0 $0
Q3 2017 Aug 13, 2024	BUY	$8.89 - $10.4 $1,333 - $1,560	150 New	150 $1.41 Million
Q1 2017 Aug 12, 2024	BUY	N/A	100 Added 66.67%	250 $2.77 Million
Q4 2016 Aug 12, 2024	BUY	N/A	150	150 $1.19 Million

2.03M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Glen Eagle Advisors, LLC with notifications on news.